|
Volumn 357, Issue 15, 2007, Pages 1472-1475
|
Hematopoietic-cell transplantation at 50
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LEUKOCYTE ANTIGEN;
ALLOGENIC BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CHROMOSOME MARKER;
CHRONIC MYELOID LEUKEMIA;
DISEASE COURSE;
GRAFT REJECTION;
GRAFT VERSUS HOST REACTION;
HEALTH CARE PERSONNEL;
HEALTH PROGRAM;
HEMATOPOIETIC CELL;
HISTOCOMPATIBILITY GENE;
HUMAN;
IMMUNOGENETICS;
IMMUNOSUPPRESSIVE TREATMENT;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
THALASSEMIA;
TREATMENT OUTCOME;
ANIMAL;
ARTICLE;
BONE MARROW TRANSPLANTATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HISTORY;
LEUKEMIA;
UNITED STATES;
ANIMALS;
BONE MARROW TRANSPLANTATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
LEUKEMIA;
UNITED STATES;
|
EID: 35248899954
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp078166 Document Type: Article |
Times cited : (362)
|
References (4)
|